News Image

NASDAQ:HALO is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

By Mill Chart

Last update: Aug 28, 2024

Our stock screener has singled out HALOZYME THERAPEUTICS INC (NASDAQ:HALO) as a stellar value proposition. NASDAQ:HALO not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. We'll explore this further.


Undervalued stocks image

Valuation Analysis for NASDAQ:HALO

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:HALO has earned a 8 for valuation:

  • Compared to the rest of the industry, the Price/Earnings ratio of HALO indicates a rather cheap valuation: HALO is cheaper than 96.84% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 30.01, HALO is valued a bit cheaper.
  • 96.66% of the companies in the same industry are more expensive than HALO, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of HALO to the average of the S&P500 Index (21.67), we can say HALO is valued slightly cheaper.
  • Based on the Enterprise Value to EBITDA ratio, HALO is valued cheaper than 95.96% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HALO is valued cheaper than 97.54% of the companies in the same industry.
  • HALO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HALO has a very decent profitability rating, which may justify a higher PE ratio.
  • HALO's earnings are expected to grow with 32.05% in the coming years. This may justify a more expensive valuation.

Profitability Insights: NASDAQ:HALO

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:HALO scores a 7 out of 10:

  • HALO's Return On Assets of 17.12% is amongst the best of the industry. HALO outperforms 98.77% of its industry peers.
  • With an excellent Return On Equity value of 116.53%, HALO belongs to the best of the industry, outperforming 99.82% of the companies in the same industry.
  • HALO has a Return On Invested Capital of 17.85%. This is amongst the best in the industry. HALO outperforms 98.07% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HALO is above the industry average of 12.95%.
  • The 3 year average ROIC (17.78%) for HALO is below the current ROIC(17.85%), indicating increased profibility in the last year.
  • HALO's Profit Margin of 38.62% is amongst the best of the industry. HALO outperforms 98.42% of its industry peers.
  • Looking at the Operating Margin, with a value of 46.33%, HALO belongs to the top of the industry, outperforming 99.65% of the companies in the same industry.
  • HALO has a Gross Margin of 79.96%. This is amongst the best in the industry. HALO outperforms 86.64% of its industry peers.

Health Examination for NASDAQ:HALO

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:HALO has received a 7 out of 10:

  • HALO has an Altman-Z score of 4.70. This indicates that HALO is financially healthy and has little risk of bankruptcy at the moment.
  • HALO's Altman-Z score of 4.70 is fine compared to the rest of the industry. HALO outperforms 77.50% of its industry peers.
  • HALO has a debt to FCF ratio of 3.68. This is a good value and a sign of high solvency as HALO would need 3.68 years to pay back of all of its debts.
  • HALO's Debt to FCF ratio of 3.68 is amongst the best of the industry. HALO outperforms 95.61% of its industry peers.
  • HALO has a Current Ratio of 7.41. This indicates that HALO is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of HALO (7.41) is better than 67.84% of its industry peers.
  • A Quick Ratio of 6.21 indicates that HALO has no problem at all paying its short term obligations.
  • HALO has a Quick ratio of 6.21. This is in the better half of the industry: HALO outperforms 61.86% of its industry peers.

How do we evaluate the Growth for NASDAQ:HALO?

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:HALO boasts a 8 out of 10:

  • HALO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.57%, which is quite impressive.
  • Measured over the past years, HALO shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.64% on average per year.
  • The Revenue has grown by 12.88% in the past year. This is quite good.
  • Measured over the past years, HALO shows a very strong growth in Revenue. The Revenue has been growing by 40.42% on average per year.
  • Based on estimates for the next years, HALO will show a very strong growth in Earnings Per Share. The EPS will grow by 25.47% on average per year.
  • The Revenue is expected to grow by 15.95% on average over the next years. This is quite good.

Our Decent Value screener lists more Decent Value stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of HALO

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

HALOZYME THERAPEUTICS INC

NASDAQ:HALO (12/20/2024, 8:16:09 PM)

After market: 46.96 0 (0%)

46.96

-0.36 (-0.76%)

Follow us for more